A Review of Antibiotic Prophylaxis for Interventional Radiology Procedures and Identification of Antimicrobial Stewardship Opportunities
Background. Antibiotics used for peri-procedural prophylaxis are dispensed by providers or nurses from automated dispensing machines in the interventional radiology (IR) suites. These antibiotics are administered without pharmacist review which skips a critical point in time for antimicrobial stewardship intervention. The purpose of this study was to evaluate antibiotic prophylaxis for IR procedures and identify opportunities for antimicrobial stewardship.
Methods. All patients who underwent an IR procedure and received antibiotic prophylaxis from April 2016 to April 2017 were identified. We performed a manual chart review to determine procedure type, antibiotic prophylaxis, concomitant systemic antibiotics, and antibiotic concordance with the Society of Interventional Radiology (SIR) guidelines.
Results. There were 410 IR procedures where the patient received a single prophylactic antibiotic dose; 261 were inpatient procedures. See Table 1 for procedure and antibiotic data. There were 74 patients (18%) who concomitantly received systemic antibiotics. There were 126 cases (31%) discordant with the SIR guidelines. Reasons for discordance include prophylaxis not recommended, inappropriate antibiotic selection, or patient already receiving an antibiotic with similar spectrum of coverage.
Conclusion. Antibiotics are frequently administered as prophylaxis for IR procedures. For many IR procedures, data to support prophylaxis is limited; however, there are opportunities for antimicrobial stewardship intervention which include optimizing antibiotic selection and withholding prophylaxis when not indicated or when patients are receiving systemic antibiotics. Background. An antibiotic time out (ATO) at 48-72 hours is a critical component of antimicrobial stewardship programs to improve judicious antibiotic use. It is a strategy to prompt clinicians to re-evaluate antibiotic appropriateness including the need for de-escalation and discontinuation. Sharp Memorial Hospital is a tertiary community hospital with 437 beds and 48 Intensive Care Unit (ICU) beds. In May 2016, an ATO program was initiated in the ICU along with the implementation of multidisciplinary daily Medical ICU rounds 5 days a week led by an intensivist.
Methods. We conducted a pre-and post-intervention study to assess the impact of an ATO on utilization of targeted antibiotics (see Table 1 ). Pharmacists received mandatory education on the components of an ATO, a reference guidebook, and completed a baseline competency prior to ATO implementation. An on demand report was used to identify patients on antibiotic day > 2. A form prompting review of indication, culture results, de-escalation, treatment duration and proton-pump inhibitor appropriateness was completed as part of the daily workflow. Interventions were discussed during rounds or by contacting the physician. Metrics included days of therapy (DOT) per 1,000 patient days, and intervention numbers, types, and acceptance rates (AR) during two 9-month periods: pre-and post-implementation.
Results. There were 829 interventions during the post-implementation period with a 96% AR compared with 83 during the pre-intervention period with a 94% AR. Antibiotic discontinuations and de-escalations comprised 52% of accepted interventions. There was a significant reduction in the use of vancomycin and quinolones with no change in anti-pseudomonal β-lactam use (see Table 1 ). Background. The core elements provide a framework for nursing homes (NH) to establish antibiotic stewardship programs (ASP). We report on implementation and sustainability of ASP through a hospital-NH partnership.
Methods. Since 2014, a hospital-based team (HBT) assisted 9 NH in Monroe County, NY in implementing ASP. Enrollment was staggered; data are currently available from 2 NH: Facility X (470 beds, full-time medical director and Infection Preventionist (IP)) and Facility Y (288 beds, part-time medical director and IP). The HBT analyzed antibiotic data to develop initial interventions focusing on reducing urinary tract infection (UTI) treatment and quinolone use. Activities included (1) regular presentation of antibiotic days of therapy (DOT), urine culture rates and treatment appropriateness; (2) coaching on interpretation and use of data to expand interventions; (3) creation of citywide guideline for diagnosis and treatment of common infections; and (4) education of nurses, providers, and families.
Results. The HBT provided drug expertise and support throughout the project; however, involvement of NH staff varied. The Facility X IP assumed responsibility for the review and feedback of urine culture data and education and the medical director educated clinicians and families on treatment guidelines. Facility Y's ASP was led by the medical director and focused mainly on education of clinicians. Facility X saw significant reductions in all metrics in 2016. Facility Y significantly reduced their quinolone use and urine culture rate; however, this did not translate into a reduction in DOT for UTI (Table 1) . 
Conclusion.
Hospital expertise can aid NH in implementing ASP core elements and changing prescribing practices. Ownership by NH staff, leadership support, and a multidisciplinary approach are key for NH ASP success. Both NH achieved improvement, however, Facility X has greater potential for sustainability due in part to a full-time IP champion that made data actionable and fostered collaboration between disciplines.
Disclosures. All authors: No reported disclosures. Background. Oral third-generation cephalosporins are often inappropriately prescribed at outpatient clinics in Japan for mild infections by viruses and bacteria susceptible to agents with a narrower spectrum despite the absence of any recommendations for the use of these drugs as a first-line treatment in the existing guidelines. Our aim was to evaluate an antimicrobial stewardship program (ASP) targeting outpatient use of oral third-cephalosporins at an emergency department.
Antimicrobial Stewardship Program for Broad-Spectrum Oral Antibiotic Use in a Pediatric
Methods. Patients visiting the emergency department (ED) at Tokyo Metropolitan Children's Medical Center in Japan between March 2010 and May 2016 were included. The first period (pre-intervention) between March 2010 and September 2010 had no ASP; the second period (intervention 1) between October 2010 and March 2013 had an ASP with consultations with an infectious diseases' physician and a no-antibiotic policy for the common cold; and the third period (intervention 2) between April 2013 and May 2016 included an ASP with the requirement for permission to prescribe oral third-generation cephalosporins. We compared the number of prescriptions for third-generation cephalosporin's prescriptions among the three periods. Antibiotic use was calculated by the number of prescriptions per 1,000 ED visits.
Results. In total 232,548 patients were included. Oral antibiotics were prescribed for 13,227 cases (5.7 %). Boys numbered 7,440 (66 %), and the median age was 54 months (IQR: 27-98 months). After interventions 1 and 2, the use of oral third-generation cephalosporins declined from 19 per 1,000 ED visits in the pre-intervention period to 6.6 per 1,000 ED visits during intervention 1 (−4.0; 95% CI −6.3 to −1.7, P = 0.001) and 0.10 per 1,000 ED visits during intervention 2 (−0.31; 95% CI −1.8 to 1.2, P = 0.675).
Conclusion. The ASP at our ED was effective in decreasing the prescription of oral third-generation cephalosporins.
Disclosures. Background. β-Lactams (BL) are optimal therapy for MSSA infections; however allergies to BL are reported frequently and may alter antibiotic selection for these infections. Limited data exist evaluating the frequency at which a new BL allergy history (AH) is taken when patients present with MSSA infections.
Methods. We conducted a 10-year retrospective review of patients treated for MSSA infections with report of BL allergy in the allergy section of the electronic medical record (EMR). Acquisition of new AH on initiation of empiric or definitive MSSA antimicrobial therapy was reviewed. Standard allergy characterization questions assess (1) age at BL reaction, (2) recollection of reaction, (3) timing from BL to reaction, (4) route of administration, (5) rationale for BL, (6) prior BL tolerance, (7) confounding medications, and (8) symptom resolution. A new AH was considered inappropriate if 0/8 items were addressed. Types of infection, types of allergic reaction, BL agents, adverse events and treatment failure rates were also analyzed.
Results. Providers seeing 142 MSSA-infected patients with EMR-based BL AH did not gather any new AH 59% of the time (83/142). Of those, 36% (30/83) of patients had an "unknown" AH in the EMR, yet no new AH was taken prior to MSSA therapy selection. When a new AH was taken, previous BL exposure (29%), recall of reaction (41%), and symptoms (83%) were the most asked questions The likelihood of exploring past BL exposure (predictor of ability to tolerate current BL) increased from 17 to 42% when 2 vs. 3 questions were assessed, respectively. Most interestingly, new provider-verified symptoms differed from prior documentation in the allergy section of the EMR 65% of the time. The most common MSSA infections treated were skin infections (34%) and bacteremia (32%). Overall, no significant differences in treatment failures and adverse events were found between patients treated with BL and non-BL therapy, perhaps due to heterogeneity of infection types.
Conclusion. In ~40% of cases, new BL allergy histories were not obtained prior to initiating treatment of MSSA infections, despite our data suggesting AH reassessment uncovers new, clinically relevant information. Routine incorporation of better AH can enhance antimicrobial stewardship programs.
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